氧化在性结肠炎中的途径:将新型病原体转化为临床实践中的承诺和挑战
Xiao-Yu Wang1, Fan An1, Ben-Jun Wang2
1The First School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250013, Shandong Province, China.
本综述讨论过氧化在性结肠炎 (UC) 中的作用,建议减少剂可能有所帮助. 然而,对于新疗法,需要进一步的临床验证和与现有的炎症性肠病 (IBD) 框架的整合.
科学领域:
- 胃肠病学 胃肠病学
- 氧化压力生物学 氧化压力生物学
背景情况:
- 性结肠炎 (UC) 是一种复杂的炎症性肠病 (IBD).
- 最近的审查建议过氧化 (H2O2) 作为UC的关键病原性因素.
- 减少剂在初步研究中显示出潜在的治疗益处.
研究的目的:
- 批判性地评估将过氧化与性结肠炎病原体联系在一起的假设.
- 讨论针对UC中氧化还原平衡的治疗方法的方法学和临床考虑.
- 评估基于氧化还原机制的整合到已建立的IBD病原模型中.
主要方法:
- 审查和分析关于过氧化和UC的现有文献.
- 检查最近一项审查中使用的证据综合方法.
- 对新型UC疗法的临床验证要求的讨论.
- 考虑已建立的IBD病原体框架.
主要成果:
- 过氧化在UC病变发生过程中所扮演的角色需要进一步研究.
- 减少剂的临床结果需要通过受控试验进行严格的验证.
- 将氧化还原机制集成到当前IBD模型中,对于治疗进步至关重要.
结论:
- 虽然新,但对UC的过氧化假设需要强有力的临床证据.
- 未来的UC疗法可能会从将基于氧化还原的机制整合到已建立的基于证据的框架中受益.
- 协作方法对于推进UC治疗至关重要,考虑到多因素病原性.
更多相关视频
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
相关概念视频
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peroxisomes
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
